{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:52:47Z","timestamp":1793865167770,"version":"4.6.1"},"reference-count":154,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.vaccine.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T18:46:55Z","timestamp":1366742815000},"page":"2723-2730","source":"Crossref","is-referenced-by-count":140,"title":["Vaccine review: \u201cStaphyloccocus aureus vaccines: Problems and prospects\u201d"],"prefix":"10.1016","volume":"31","author":[{"given":"Kathrin U.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Q.","family":"Girgenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid L.","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMp1100251","article-title":"How Staphylococcus aureus adapts to its host","volume":"364","author":"Lowy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/590124","article-title":"Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus","volume":"29","author":"Anderson","year":"2008","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1086\/502424","article-title":"Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery","volume":"25","author":"Harrington","year":"2004","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0025","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/428626","article-title":"The effect of increasing age on the risk of surgical site infection","volume":"191","author":"Kaye","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/JCM.02235-10","article-title":"Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers","volume":"49","author":"Miller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0035","article-title":"MRSA in a large German University Hospital: male gender is a significant risk factor for MRSA acquisition","volume":"5","author":"Kupfer","year":"2010","journal-title":"GMS Krankenh Interdiszipl"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0040","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1002\/cncr.25286","article-title":"Severe neutropenia at time of port insertion is not a risk factor for catheter-associated infections in children with acute lymphoblastic leukemia","volume":"116","author":"Junqueira","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/652451","article-title":"Hospitalization earlier than 1 year prior to admission as an additional risk factor for methicillin-resistant Staphylococcus aureus colonization","volume":"31","author":"McAllister","year":"2010","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chom.2010.11.002","article-title":"Specificity for human hemoglobin enhances Staphylococcus aureus infection","volume":"8","author":"Pishchany","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.01030-12","article-title":"Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis","volume":"81","author":"Veloso","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0060","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus","author":"Del Giudice","year":"2011","journal-title":"Rev Presse Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajic.2006.12.009","article-title":"Community-associated methicillin-resistant Staphylococcus aureus prevalence: how common is it, A methodological comparison of prevalence ascertainment","volume":"35","author":"Furuya","year":"2007","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0002-9343(88)80337-1","article-title":"Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex","volume":"85","author":"Jacobson","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/14787210.6.6.909","article-title":"Treatment and recurrence management of staphylococcal infections: community-acquired MRSA","volume":"6","author":"Kale-Pradhan","year":"2008","journal-title":"Exp Rev Anti-infect Therapy"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PEC.0b013e318243fa36","article-title":"Changes in community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections presenting to the pediatric emergency department: comparing 2003\u20132008","volume":"28","author":"Karamatsu","year":"2012","journal-title":"Pediat Emerg Care"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.idc.2008.10.002","article-title":"Staphylococcus aureus: a community pathogen","volume":"23","author":"Miller","year":"2009","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijantimicag.2011.09.029","article-title":"Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA)","volume":"39","author":"Skov","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/erv.11.54","article-title":"Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines","volume":"10","author":"Broughan","year":"2011","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2041-1014.2011.00628.x","article-title":"Molecular mechanisms of Staphylococcus aureus nasopharyngeal colonization","volume":"27","author":"Edwards","year":"2012","journal-title":"Mol Oral Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0966-842X(01)02254-5","article-title":"What determines nasal carriage of Staphylococcus aureus","volume":"9","author":"Peacock","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.idc.2008.10.003","article-title":"Pathogenesis in Staphylococcus aureus infections","volume":"23","author":"DeLeo","year":"2009","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0966-842X(00)01803-5","article-title":"Staphylococcus aureus an intracellular pathogen","volume":"8","author":"Is","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-011-0300-x","article-title":"Colonization, pathogenicity, host susceptibility, and therapeutics for &lt;i&gt;Staphylococcus aureus&lt;\/i&gt;: what is the clinical relevance","volume":"34","author":"Tong","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-011-0294-4","article-title":"Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity","volume":"34","author":"Cassat","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-6445(03)00052-4","article-title":"Emerging themes in manganese transport, biochemistry and pathogenesis in bacteria","volume":"27","author":"Kehres","year":"2003","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0135","doi-asserted-by":"crossref","first-page":"e1000949","DOI":"10.1371\/journal.ppat.1000949","article-title":"The battle for iron between bacterial pathogens and their vertebrate hosts","volume":"6","author":"Skaar","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2741\/1317","article-title":"Mn2+ and bacterial pathogenesis","volume":"9","author":"Zaharik","year":"2004","journal-title":"Front Biosci J Virt Library"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1432-1033.1997.00416.x","article-title":"Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen","volume":"247","author":"McDevitt","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tim.2011.01.007","article-title":"A play in four acts: Staphylococcus aureus abscess formation","volume":"19","author":"Cheng","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/cmi.12002","article-title":"Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components","volume":"14","author":"Chagnot","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-0940-9_7","article-title":"Adhesion mechanisms of staphylococci","volume":"715","author":"Heilmann","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1797.2008.01069.x","article-title":"Review article: the role of CD4(+) T cells in ANCA-associated systemic vasculitis","volume":"14","author":"Abdulahad","year":"2009","journal-title":"Nephrology"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/CMR.18.3.521-540.2005","article-title":"Recognition of Staphylococcus aureus by the innate immune system","volume":"18","author":"Fournier","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/emmm.201100123","article-title":"Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus","volume":"3","author":"Garzoni","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mib.2011.10.012","article-title":"Recurrent infections and immune evasion strategies of Staphylococcus aureus","volume":"15","author":"Kim","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00281-011-0292-6","article-title":"Innate and adaptive immune responses against Staphylococcus aureus skin infections","volume":"34","author":"Krishna","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-011-0291-7","article-title":"Immunopathogenesis of Staphylococcus aureus pulmonary infection","volume":"34","author":"Parker","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0195","doi-asserted-by":"crossref","DOI":"10.4161\/hv.21872","article-title":"Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors","volume":"8","author":"Anderson","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0200","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/infdis\/jis272","article-title":"Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis","volume":"205","author":"Anderson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cid\/cis033","article-title":"Challenges for a universal Staphylococcus aureus vaccine","volume":"54","author":"Proctor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0210","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/cir828","article-title":"Toward a Staphylococcus aureus vaccine","volume":"54","author":"Daum","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0215","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1600-6143.2011.03476.x","article-title":"IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice","volume":"11","author":"Ahmed","year":"2011","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2011-12-399931","article-title":"IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and FcgammaRIIa in human dendritic cells","volume":"120","author":"den Dunnen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0225","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/IAI.00191-12","article-title":"Host response signature to Staphylococcus aureus alpha-hemolysin implicates pulmonary Th17 response","volume":"80","author":"Frank","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/eji.200939929","article-title":"Divergent roles of Toll-like receptor 2 in response to lipoteichoic acid and Staphylococcus aureus in vivo","volume":"40","author":"Gillrie","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/IAI.00724-09","article-title":"Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells","volume":"78","author":"Islander","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0240","doi-asserted-by":"crossref","first-page":"0","DOI":"10.4161\/hv.18946","article-title":"Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17\/IL17 pathway in a murine sepsis model","volume":"8","author":"Joshi","year":"2012","journal-title":"Hum Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0245","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/all.12001","article-title":"Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses","volume":"67","author":"Kim","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0250","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1128\/IAI.00958-10","article-title":"Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans","volume":"79","author":"Niebuhr","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fcimb.2012.00036","article-title":"Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB)","volume":"2","author":"Pancari","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0260","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/IAI.01386-10","article-title":"Murine immune response to a chronic Staphylococcus aureus biofilm infection","volume":"79","author":"Prabhakara","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0265","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0270","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","article-title":"Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3","volume":"205","author":"Ma","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0275","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(87)91372-9","article-title":"Selective immunodeficiency affecting staphylococcal response","volume":"2","author":"Monteil","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0280","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mib.2003.12.004","article-title":"How do neutrophils and pathogens interact","volume":"7","author":"Mayer-Scholl","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0285","doi-asserted-by":"crossref","first-page":"a002980","DOI":"10.1101\/cshperspect.a002980","article-title":"The signaling mechanisms underlying cell polarity and chemotaxis","volume":"1","author":"Wang","year":"2009","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0290","article-title":"Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus","volume":"9","author":"Nanra","year":"2012","journal-title":"Hum Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0295","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0300","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI105568","article-title":"In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood","volume":"46","author":"Quie","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0305","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI108055","article-title":"The role of superoxide anion generation in phagocytic bactericidal activity, Studies with normal and chronic granulomatous disease leukocytes","volume":"55","author":"Johnston","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0310","series-title":"Hematology of infancy and childhood","author":"Curnutte","year":"1993"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0315","series-title":"Harrison's principles of internal medicine","author":"Handin","year":"1998"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0320","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1128\/IAI.68.11.6398-6401.2000","article-title":"A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection","volume":"68","author":"Lorenz","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0325","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0330","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.vaccine.2011.11.006","article-title":"Is there a future for a Staphylococcus aureus vaccine","volume":"30","author":"Proctor","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0335","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3171\/2009.5.JNS081589","article-title":"Perioperative management of neurosurgical patients with methicillin-resistant Staphylococcus aureus","volume":"112","author":"Akins","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0340","first-page":"179","article-title":"Gram-positive bacterial resistance, a challenge for the next millennium","volume":"44","author":"Bassetti","year":"2002","journal-title":"Panminerva Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0345","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/cid\/cir473","article-title":"The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes","volume":"53","author":"Cameron","year":"2011","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0350","first-page":"1341","article-title":"Spinal epidural abscess: a diagnostic challenge","volume":"65","author":"Chao","year":"2002","journal-title":"Am Family Phys"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0355","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006231-200608000-00007","article-title":"Osteomyelitis: clinical update for practical guidelines","volume":"27","author":"Concia","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0360","first-page":"218","article-title":"Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens","volume":"15","author":"Cornaglia","year":"2009","journal-title":"Clin Microbiol Infect Off Pub Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0365","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01720610-200905000-00006","article-title":"The antibiotic challenge: changing clinical management of infections","volume":"22","author":"Deasy","year":"2009","journal-title":"JAAPA"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0370","first-page":"1154","article-title":"Control of endemic methicillin-resistant Staphylococcus aureus \u2013 recent advances and future challenges","volume":"12","author":"Harbarth","year":"2006","journal-title":"Clin Microbiol Infect Off Pub Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1368-7646(98)80029-0","article-title":"Vancomycin resistance in staphylococci","volume":"1","author":"Hiramatsu","year":"1998","journal-title":"Drug Resist Updates Rev Comment Antimicrob Anticancer Chemother"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0380","first-page":"310","article-title":"Osteomyelitis: a current challenge","volume":"14","author":"Jorge","year":"2010","journal-title":"Braz J Infect Dis Off Pub Braz Soc Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0385","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ajic.2006.03.008","article-title":"Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature","volume":"34","author":"Aboelela","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0390","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0775","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/CVI.00354-12","article-title":"A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure","volume":"19","author":"Hawkins","year":"2012","journal-title":"Clin Vaccine Immunol."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0400","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-0-387-73960-1_5","article-title":"Current status of group A streptococcal vaccine development","volume":"609","author":"Dale","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0405","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0410","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0415","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/clinids\/17.1.66","article-title":"Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination","volume":"17","author":"Musher","year":"1993","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0420","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/CVI.00354-12","article-title":"A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure","volume":"19","author":"Hawkins","year":"2012","journal-title":"CVI"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0425","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CVI.05589-11","article-title":"Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency","volume":"19","author":"Tkaczyk","year":"2012","journal-title":"CVI"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0430","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/infdis\/jis463","article-title":"Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice","volume":"206","author":"Mishra","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0435","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1016\/j.vaccine.2010.02.097","article-title":"IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge","volume":"28","author":"Kim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0440","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/CVI.00356-10","article-title":"Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans","volume":"17","author":"Harro","year":"2010","journal-title":"CVI"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0445","unstructured":"Fowler VG AK, Moreira E, Moustafa M, Isgro F, Boucher H, FIDSA, et al. Efficacy and safety of an investigational Staphylococcus aureus vaccine in preventing bacteremia and deep sternal wound infections after cardiothoracic surgery. IDWeek. San Diego, CA; 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0450","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00085-09","article-title":"Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo","volume":"16","author":"Brown","year":"2009","journal-title":"CVI"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/HAB-2010-0235","article-title":"A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo","volume":"19","author":"Ebert","year":"2010","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0460","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0465","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.vaccine.2003.11.034","article-title":"Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials","volume":"22","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0470","unstructured":"Matalon AM, M.; Buerkert, J.; Block, G; Hohenboken, M.; Fattom, A.; Horwirth, G., Rasmussen, H., Damasco, S.; Boutriau, D. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugate investigational vaccine in adults on haemodialysis: Phase III randomized study. International symposium on staphylococcal infections. Lyon, France; 2012. p. 9\u2013114."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0475","unstructured":"Richmond PNM, Marshall H, Shakib S, Hodsman P, Jiang Q, Cooper D, et al. Safety, Tolerability, and Immunogenicity of a novel 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: results of a randomized, placebo controlled Phase 1 first-in-human study. IDWeek. San Diego, CA; 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0480","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2249.2009.03950.x","article-title":"The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes","volume":"157","author":"Anwar","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2911(06)51004-5","article-title":"Surface adhesins of Staphylococcus aureus","volume":"51","author":"Clarke","year":"2006","journal-title":"Adv Microb Phys"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0490","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jis272","article-title":"The Staphylococcus aureus transporter MntC is a highly conserved cell surface protein that elicits protective immunity against both S. aureus and Staphylococcus epidermidis","author":"Anderson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0495","doi-asserted-by":"crossref","first-page":"16942","DOI":"10.1073\/pnas.0606863103","article-title":"Vaccine assembly from surface proteins of Staphylococcus aureus","volume":"103","author":"Stranger-Jones","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0500","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcimb.2012.00016","article-title":"Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials","volume":"2","author":"Bagnoli","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0505","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.coph.2003.05.005","article-title":"Passive immunization as prophylaxis: when and where will this work","volume":"3","author":"Dunman","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0510","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.coph.2006.04.005","article-title":"Staphylococcal vaccines and immunotherapy: to dream the impossible dream","volume":"6","author":"Projan","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0515","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1128\/IAI.64.5.1839-1841.1996","article-title":"Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model","volume":"64","author":"Menzies","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0520","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20072208","article-title":"Vaccine protection against Staphylococcus aureus pneumonia","volume":"205","author":"Bubeck Wardenburg","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0525","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/cid\/cis033","article-title":"Challenges for a universal Staphylococcus aureus vaccine","volume":"54","author":"Proctor","year":"2012","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0530","doi-asserted-by":"crossref","first-page":"e41454","DOI":"10.1371\/journal.pone.0041454","article-title":"Innate immune dysfunctions in aged mice facilitate the systemic dissemination of methicillin-resistant S. aureus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0535","series-title":"Estimates of Invasive Methicillin-Resistant Staphylococcus aureus Infection Rates by Specific Population Groups. ID Week. San Diego","author":"Fagan","year":"2012"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0540","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/02688690500145639","article-title":"Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4578 patients","volume":"19","author":"Korinek","year":"2005","journal-title":"Brit J Neurosurg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0545","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1540-8167.2009.01690.x","article-title":"Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences","volume":"21","author":"Nery","year":"2010","journal-title":"J Cardiovas Electrophysiol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0550","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1302\/0301-620X.87B6.15121","article-title":"Infection of the surgical site after arthroplasty of the hip","volume":"87","author":"Ridgeway","year":"2005","journal-title":"J Bone Joint Surg Brit Vol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0555","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cid\/cir506","article-title":"Risk factors for surgical site infections following spinal fusion procedures: a case\u2013control study","volume":"53","author":"Rao","year":"2011","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0560","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project","volume":"38","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0565","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/infdis\/173.4.963","article-title":"Surgical site infections occurring after hospital discharge","volume":"173","author":"Sands","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0570","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1471-0528.2012.03452.x","article-title":"Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study","volume":"119","author":"Wloch","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0575","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/archinte.167.19.2073","article-title":"Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients","volume":"167","author":"Bleasdale","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0580","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/518347","article-title":"Increase in the rate of sternal surgical site infection after coronary artery bypass graft: a marker of higher severity of illness","volume":"28","author":"Fakih","year":"2007","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0585","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0196-6553(98)80009-6","article-title":"Wound infections after hysterectomy: opportunities for practice improvement","volume":"26","author":"Taylor","year":"1998","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0590","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00266-009-9427-8","article-title":"Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration","volume":"34","author":"Khan","year":"2010","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0595","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0600","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000441-199410000-00008","article-title":"Case report: diabetes mellitus as a predisposing factor in the development of pyomyositis","volume":"308","author":"Belsky","year":"1994","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0605","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajic.2009.08.016","article-title":"Exposure to hospital roommates as a risk factor for health care-associated infection","volume":"38","author":"Hamel","year":"2010","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0610","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jvs.2004.03.020","article-title":"Infected aortic aneurysms: clinical outcome and risk factor analysis","volume":"40","author":"Hsu","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0615","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archinte.159.13.1437","article-title":"Risk factors for hospital-acquired Staphylococcus aureus bacteremia","volume":"159","author":"Jensen","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0620","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/665728","article-title":"Prospective nationwide surveillance of surgical site infections after gastric surgery and risk factor analysis in the Korean Nosocomial Infections Surveillance System (KONIS)","volume":"33","author":"Kim","year":"2012","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0625","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1440-1622.2000.01742.x","article-title":"Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery","volume":"70","author":"Spelman","year":"2000","journal-title":"Austr NZ J Surg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0630","first-page":"641","article-title":"A prospective study of prevalence of 60-days postoperative wound infections after cardiac surgery, an updated risk factor analysis","volume":"48","author":"Centofanti","year":"2007","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0635","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/420819","article-title":"Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus","volume":"38","author":"Dodds Ashley","year":"2004","journal-title":"Clin Infect Dis Off Pub Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0640","first-page":"35","article-title":"Preoperative risk factors for postoperative Staphylococcus aureus nosocomial infections","volume":"13","author":"Fang","year":"2004","journal-title":"Surg Technol Int"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0645","first-page":"815","article-title":"Smoking as a risk factor for wound healing and infection in breast cancer surgery","volume":"28","author":"Sorensen","year":"2002","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Brit Assoc Surg Oncol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0650","unstructured":"Yu H, Mardekian J, Strutton D, Girgenti D. Characterizing Staphylococcus aureus infections following elective surgeries in US hospitals. International conference on antimicrobial agents and chemotherapeutics. San Francisco, CA; 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0655","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhin.2011.06.015","article-title":"A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done","volume":"79","author":"Fitzgerald","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0660","first-page":"183","article-title":"T cells and B cells in chronic renal failure","volume":"16","author":"Descamps-Latscha","year":"1996","journal-title":"Semin Nephrol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.04.002_bib0665","first-page":"S37","article-title":"The immune status of the uremic patient: hemodialysis vs CAPD","volume":"30","author":"Schollmeyer","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0670","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000169435","article-title":"Immune abnormalities in renal failure and hemodialysis","volume":"4","author":"Kay","year":"1986","journal-title":"Blood Purif"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0675","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000074959","article-title":"Imbalanced cytokine secretion in newborns","volume":"85","author":"Kotiranta-Ainamo","year":"2004","journal-title":"Biol Neonate"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0680","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1189\/jlb.0403179","article-title":"Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens","volume":"75","author":"Chelvarajan","year":"2004","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0685","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clim.2005.10.012","article-title":"Innate cellular immune responses in newborns","volume":"118","author":"Marodi","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0690","unstructured":"Merck. Efficacy, Immunogenicity, and safety of a single dose of V710 in adult patients scheduled for cardiothoracic surgery (V710-003 AM2). ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0695","unstructured":"NabiBiopharmaceuticals. Study to evaluate the effectiveness of StaphVAX in adults on hemodialysis. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2006."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0700","unstructured":"NabiBiopharmaceuticals. StaphVAX in cardiovascular surgery patients. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2007."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0705","unstructured":"Bristol-Myers_Squibb. Safety and efficacy of Veronate\u00ae versus placebo in preventing nosocomial staphylococcal sepsis in premature infants. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2006."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0710","unstructured":"Biosynexus_Incorporated. Safety and efficacy of pagibaximab injection in very low birth weight neonates for prevention of staphylococcal sepsis. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2011."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0715","unstructured":"Pfizer evaluation of a single vaccination of one of three ascending dose levels of a 4-antigen staphylococcus aureus vaccine (SA4Ag) and a single dose level of a 3-antigen staphylococcus aureus vaccine (SA3Ag) in healthy adults aged 65 to <86years. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0720","unstructured":"Uniformed_Services_University_of_the_Health_Sciences. Staphylococcus aureus toxoids phase 1\u20132 vaccine trial. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0725","unstructured":"GlaxoSmithKline. A study to evaluate the safety, reactogenicity and immunogenicity of GSK biologicals\u2019 staphylococcal investigational vaccine in healthy adults. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0730","doi-asserted-by":"crossref","unstructured":"Vaccine_Research_International_Plc. Phase I trial. Birmingham, UK. Vaccine Research International Plc; 2013.","DOI":"10.1016\/S1365-6937(13)70362-9"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0735","unstructured":"Sanofi. Pharmacokinetics, Pharmacodynamics and safety evaluation of SAR279356 in intensive care unit mechanically ventilated patients. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2013."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0740","unstructured":"NabiBiopharmaceuticals. Safety study of an intravenous staphylococcus aureus immune globulin (human), [altastaph] in low-birth-weight-neonates. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0745","unstructured":"Inhibitex Aurexis\u00ae in cystic fibrosis subjects chronically colonized with Staphylococcus aureus in their lungs. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2006."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0750","unstructured":"Inhibitex clinical trial comparing safety and pharmacokinetics of standard antibiotic therapy, plus Aurexis\u00ae or placebo, for treatment of Staphylococcus aureus bacteremia (SAB). ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2005."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0755","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1128\/AAC.00570-07","article-title":"Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia","volume":"51","author":"Rupp","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2013.04.002_bib0760","unstructured":"NabiBiopharmaceuticals. Safety and behavior of S. Aureus immune globulin intravenous (human), [altastaph] in patients with S. aureus bacteremia and continuing fever. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2012."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0765","unstructured":"Kenta_Biotech_Ltd. Safety, pharmacokinetics and efficacy of KBSA301 in severe pneumonia (S. aureus). ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2013."},{"key":"10.1016\/j.vaccine.2013.04.002_bib0770","unstructured":"NeuTec_Pharma. Aurograb and vancomycin in MRSA infection. ClinicalTrialsgov. Bethesda, MD: National Library of Medicine (US); 2006."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:26:36Z","timestamp":1715257596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13004210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":154,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0264410X13004210"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}